tiprankstipranks
Trending News
More News >
Smith & Nephew Snats (SNN)
NYSE:SNN
US Market

Smith & Nephew Snats (SNN) Earnings Dates, Call Summary & Reports

Compare
198 Followers

Earnings Data

Report Date
Jul 30, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
1
Last Year’s EPS
0.86
Same Quarter Last Year
Based on 2 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Mar 02, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed strong execution and momentum: double-digit improvement in key profitability and cash metrics for FY2025 (margin expansion, $840M free cash flow, adjusted EPS +21%), broad-based revenue growth across business units, record adoption of CORI robotics, and clear cost-savings progress. Management provided constructive FY2026 guidance (~6% organic revenue growth, ~8% trading profit growth) and a disciplined capital allocation approach including targeted M&A (Integrity) aligned with strategy. Offsetting these positives are significant, but largely manageable, near-term headwinds: China VBP effects (now smaller on top line but still weighing on profit), CMS skin-substitute reimbursement changes (material near-term pressure on that subcategory), tariff and reimbursement impacts, and a one-off $159M portfolio rationalization charge. Overall the positives (growth, margin expansion, cash generation, innovation pipeline and cost savings) materially outweigh the near-term challenges and one-off charges, with a credible plan to offset headwinds and deliver further improvement over the medium term.
Company Guidance
Smith & Nephew guided 2026 to around 6% organic revenue growth and roughly 8% organic trading profit growth (with trading profit expected to grow ahead of revenue), and advised total trading profit of about $1.3 billion including the Integrity Orthopaedics acquisition (marginally dilutive in 2026, broadly neutral in 2027 and accretive in 2028). Management expects free cash flow of ~ $800 million in 2026, group ROIC >10% excluding Integrity, and finished 2025 with leverage of ~1.7x adjusted net debt/EBITDA (buybacks to be considered subject to a ~2x target), while maintaining a dividend payout ratio of 35–40%. Guidance is phased to a stronger second half (H1 revenue growth ~4.5–5% and H2 ~7.5–8%; profit growth H1 ~5.5–6% and H2 ~9–10%), factors in one fewer trading day in Q1 and one extra in Q4, and assumes headwinds of c.$60m from tariffs (vs $17m in 2025) and $20–40m incremental impact from wound reimbursement that management expects to more than offset via ~ $150m of savings in 2026 plus revenue leverage. The company also reiterated its mid‑term RISE ambitions of 6–7% organic revenue CAGR, 9–10% trading profit CAGR, >$1bn free cash flow in 2028 and 12–13% ROIC by 2028.
Full-Year Revenue Growth
FY2025 revenue of $6.2B, up 5.3% underlying (6.1% reported), ahead of guidance; 2022–2025 revenue CAGR of 5.7%.
Strong Q4 Performance
Q4 revenue of $1.7B, up 6.2% underlying and 8.3% reported (210 bps FX tailwind); average daily sales growth of 4.5% and broad-based regional growth (U.S. +5.6%, other established +7.2%, emerging +6.4%).
Margin Expansion and Trading Profit
Trading profit rose to $1.2B for the year (+$162M year-on-year) and trading margin expanded 160 basis points to 19.7% in FY2025 (gross margin 70.9%, +60 bps).
Cash Generation and Returns
Free cash flow of $840M, up 52.5% year-on-year and well ahead of initial guidance (> $600M); net debt $2.76B with leverage ~1.7x adjusted net debt/EBITDA; ROIC improved to 8.3% (9.9% excluding portfolio rationalization).
Operational Progress and Cost Savings
Cumulative efficiency savings of $280M achieved to end-2025 against a $325–375M by-2027 target; 160 bps FY25 margin expansion driven by enterprise-wide cost savings, manufacturing optimization, productivity and portfolio rationalization; group days sales inventory reduced materially (group DSI down 21 days excl. rationalization, 51 days incl.).
Innovation-led Growth
Over 60% of 2025 growth came from products launched in the last five years; 44 product launches over the last 3 years and guidance to launch 16 products in 2026; record CORI placements globally with 45% of CORI placements in ASCs and CORI-associated accounts showing Knee growth ~850 bps higher.
Portfolio and Capital Actions
Completed $500M share buyback in H2 2025; adjusted EPS grew 21% to $1.02 (benefitting from buyback); full-year dividend proposed +4.3% to $0.391; announced acquisition of Integrity Orthopaedics (up to $450M) to strengthen shoulder/rotator cuff franchise.

Smith & Nephew Snats (SNN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SNN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 30, 2026
2026 (Q2)
1.00 / -
0.858
Mar 02, 2026
2025 (Q4)
1.16 / 1.18
0.93826.01% (+0.24)
Aug 05, 2025
2025 (Q2)
0.79 / 0.86
0.75613.49% (+0.10)
Feb 25, 2025
2024 (Q4)
0.92 / 0.94
0.958-2.09% (-0.02)
Aug 01, 2024
2024 (Q2)
0.79 / 0.76
0.78.00% (+0.06)
Feb 27, 2024
2023 (Q4)
0.97 / 0.96
0.8710.11% (+0.09)
Aug 03, 2023
2023 (Q2)
0.73 / 0.70
0.762-8.14% (-0.06)
Feb 21, 2023
2022 (Q4)
0.73 / 0.87
0.88.75% (+0.07)
Jul 28, 2022
2022 (Q2)
0.76 / 0.76
0.776-1.80% (-0.01)
Feb 22, 2022
2021 (Q4)
0.87 / 0.80
1.026-22.03% (-0.23)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SNN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 02, 2026
$36.90$35.76-3.09%
Aug 05, 2025
$30.55$35.20+15.23%
Feb 25, 2025
$25.66$27.45+6.96%
Aug 01, 2024
$27.85$29.77+6.88%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Smith & Nephew Snats (SNN) report earnings?
Smith & Nephew Snats (SNN) is schdueled to report earning on Jul 30, 2026, Before Open (Confirmed).
    What is Smith & Nephew Snats (SNN) earnings time?
    Smith & Nephew Snats (SNN) earnings time is at Jul 30, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SNN EPS forecast?
          SNN EPS forecast for the fiscal quarter 2026 (Q2) is 1.